TriVerity— 510(k) K241676

Substantially Equivalent

Inflammatix, Inc.

FDA 510(k) clearance K241676 for TriVerity, Substantially Equivalent on 2025-01-10. Applicant: Inflammatix, Inc..

Clearance details

Applicant: Inflammatix, Inc.
Product code: Code PRE
Advisory panel: Microbiology
Date received: 2024-06-11
Decision date: 2025-01-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Sunnyvale, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.